5
µ¦¦³»
¤ª·
µµ¦Â¨³Á°¨µª·
´
¥¤®µª·
¥µ¨´
¥´
¬·
¦´Ê
¸É
19
¦³Î
µe
2552
缃
°µ¤¸
¦·
¤µÃ¦¸
¸É
´
Åo
o
°¥ªn
µµ¦´
o
ª¥´
¢Á¢°¦r
¸É
¡¸
Á°¼
¨³¦·
¤µÁ°Å¤r
¸É
Åo
o
°¥¹
Ťn
Á®¤µ³¤¸É
³Äo
ĵ¦´
Á°Å¤r
ŨÁ
µ¦Â¥Á°Å¤r
ŨÁo
ª¥¦³µ¦¨³¨µ¥ÊÎ
µ°ª´
£µ
µ¦Â¥Á°Å¤r
ŨÁµÁºÊ
°¤³¡¦o
µªÃ¥Äo
¦³µ¦¨³¨µ¥ÊÎ
µ°ª´
£µ
Ã¥Äo
5% 10% 15% ¨³
20 %
° Polyethylene glycol 1500
´
笼
° Tripotassium citrate Î
µµ¦´
Á°Å¤r
¤µ¤´
Polyethylene
glycol 1500 µ¤Á°¦r
ÁÈ
r
¸É
Î
µ® ¹É
³o
°Äo
¦·
¤µÁ¨º
° Tripotassium citrate ´
µ¦µ¸É
2 ¨³¦·
¤µ
Á°Å¤r
ŨÁÄ´Ê
n
µ Ç
°µ¦Â¥Ã¥Äo
5 -10 % Polyethylene glycol 1500 ´
µ¦µ¸É
3 ¨³£µ¡µ¦Â¥
°°Á}
2 ´Ê
´
£µ¡¸É
1
µ¦µ¸É
2 ÂÁ°¦r
ÁÈ
r
笼
° Tripotassium citrate
Treatment
%Salt
PEG phase (ml)
Salt phase (ml)
Total volume
5%PEG
27.50
2.00
20.50
24.00
10%PEG
25.35
4.50
18.00
24.50
15%PEG
19.90
8.00
15.50
25.00
20%PEG
17.45
11.00
12.00
26.00
£µ¡¸É
1 µ¦Â¥Á°Å¤r
ŨÁµ¤³¡¦o
µªÃ¥Äo
¦³µ¦¨³¨µ¥ÊÎ
µ°ª´
£µ(ATPS)
µ¨¸É
Åo
¡ªn
µµ¦Á¡·É
¤ªµ¤Á
o
¤
o
°¡°¨·
Á¤°¦r
¤µ
¹Ê
È
³Äo
ªµ¤Á
o
¤
o
°Á¨º
°¨¨ µÁ®»
¸É
Î
µ
Įo
Á·
µ¦Â¥ÁºÉ
°µ Á¡·É
¤ªµ¤Á
o
¤
o
°¡°¨·
Á¤°¦r
¨³Á¨º
°Á}
µ¦Á¡·É
¤Â¦¹
·
ª (interfacial tensions) Î
µÄ®o
µ¤µ¦Á·
µ¦Â¥Åo
¸
¹Ê
Ã¥µ¦Á¡·É
¤ªµ¤Á
o
¤
o
°¡°¨·
Á¤°¦r
®¦º
°Á¨º
°Ä®o
¼
¹Ê
³Á}
µ¦Î
µÄ®o
Á·
µ¦Â¥
´Ê
°µ¦®¦º
°Ã¦¸
Å°¥¼n
Ä´Ê
Ä´Ê
®¹É
¤µ¹Ê
Salt phase
PEG phase
Salt phase
PEG phase